SAVA FY 2013 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$41M+277.6% YoY

Gross Profit

$41M100.0% margin

Operating Income

$31M76.3% margin

Net Income

$32M76.7% margin

EPS (Diluted)

$4.90

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$50M

Total Liabilities

$2M

Stockholders' Equity

$48M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$11M	+277.6%
Gross Profit	$41M	$11M	+277.8%
Operating Income	$31M	-$4M	+904.8%
Net Income	$32M	-$3M	+1015.4%